Silo Pharma (SILO) Assets Average (2011 - 2026)
Silo Pharma (SILO) posted Assets Average of $7.3 million for Q1 2026, up 4.53% sequentially from $7.0 million in Q4 2025, and up 9.85% YoY from $6.7 million in Q1 2025.
Silo Pharma (SILO) Assets Average (2011 - 2026) Analysis & Trends
Silo Pharma has reported Assets Average for 12 years, with the latest figure at $7.3 million in Q1 2026.
- Quarterly Assets Average rose 9.85% year-over-year to $7.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.3 million (up 9.85% YoY) and the FY2025 annual result came in at $7.5 million, down 0.93% from the prior year.
- Assets Average improved to $7.3 million in Q1 2026 per SILO's latest filing, from $7.0 million in the prior quarter.
- Over five years, Assets Average peaked at $12.3 million in Q4 2022 and troughed at $6.3 million in Q2 2025.
- A 5-year average of $8.7 million and a median of $8.3 million in 2024 frame the typical range for Assets Average.
- The sharpest annual moves came in 2022 and 2024: Assets Average jumped 191.66% in 2022, then tumbled 35.2% in 2024.
- Over 5 years, Assets Average stood at $12.3 million in 2022, then slumped by 32.23% to $8.4 million in 2023, then slipped by 4.51% to $8.0 million in 2024, then dropped by 12.45% to $7.0 million in 2025, then grew by 4.53% to $7.3 million in 2026.
- According to Business Quant data, Assets Average over the past three periods registered $7.3 million, $7.0 million, and $6.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.83 Bn | 130.98 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 85.79 Bn | 77.79 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 64.95 Bn | 59.77 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.59 Bn | 53.46 Bn | 52.00 Mn | 11.22 Bn |
| 5 | BeOne Medicines | 41.93 Bn | 36.83 Bn | 1.53 Bn | 8.86 Bn |
| 6 | Alnylam Pharmaceuticals | 31.52 Bn | 28.21 Bn | 992.69 Mn | 5.34 Bn |
| 7 | BioNTech SE | 27.98 Bn | 9.58 Bn | 668.28 Mn | 25.27 Bn |
| 8 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | 2.09 Bn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 19.82 Bn |
| 10 | Silo Pharma | 2.96 Mn | 2.96 Mn | - | 6.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.49 Mn |
| Mar 31, 2026 | 7.31 Mn |
| Dec 31, 2025 | 6.99 Mn |
| Sep 30, 2025 | 6.52 Mn |
| Jun 30, 2025 | 6.28 Mn |
| Mar 31, 2025 | 6.66 Mn |
| Dec 31, 2024 | 7.99 Mn |
| Sep 30, 2024 | 8.30 Mn |
| Jun 30, 2024 | 7.49 Mn |
| Mar 31, 2024 | 7.34 Mn |
| Dec 31, 2023 | 8.37 Mn |
| Sep 30, 2023 | 9.62 Mn |
| Jun 30, 2023 | 10.63 Mn |
| Mar 31, 2023 | 11.33 Mn |
| Dec 31, 2022 | 12.35 Mn |
| Sep 30, 2022 | 11.05 Mn |
| Jun 30, 2022 | 9.38 Mn |
| Mar 31, 2022 | 10.10 Mn |
| Dec 31, 2021 | 10.94 Mn |
| Sep 30, 2021 | 8.20 Mn |